Boston Scientific Completes Acquisition of Bolt Medical and Receives FDA Approval for IVL Technology
April 3, 2025 - 22:18
Boston Scientific has successfully finalized its acquisition of Bolt Medical, a strategic move aimed at enhancing its portfolio in the medical technology sector. This acquisition comes on the heels of the FDA granting clearance for Bolt Medical’s innovative Intravascular Lithotripsy (IVL) technology, which is designed to treat calcified coronary artery disease.
The IVL system utilizes sonic pressure waves to break down calcium deposits in arteries, facilitating easier stenting procedures. This breakthrough technology is expected to significantly improve patient outcomes and expand treatment options for those suffering from complex cardiovascular conditions.
With the acquisition now complete, Boston Scientific is optimistic about the future. The company plans to officially launch its new IVL system in the first half of 2026, marking a significant advancement in cardiovascular care. This development is anticipated to strengthen Boston Scientific's position in the competitive medical device market, providing healthcare professionals with innovative solutions to enhance patient care.
MORE NEWS
May 20, 2026 - 01:02
How Google Is Starting to Win the A.I. RaceAfter a rocky start that saw ChatGPT steal the spotlight, Google is quietly pulling ahead in the artificial intelligence competition. The company`s Gemini model has not only caught up to OpenAI`s...
May 19, 2026 - 12:35
Urgent Notice to All Chinese EB-5 Investors: Increased USCIS Scrutiny of Applicants Connected to Certain Chinese Technology CompaniesU.S. Citizenship and Immigration Services is ramping up national security reviews for EB-5 immigrant investor petitions tied to certain Chinese technology companies. Recent cases show that USCIS is...
May 18, 2026 - 20:32
AI CEOs Baffled by Hatred of Their TechnologyRecent polling data reveals a persistent and widespread dislike of artificial intelligence among many Americans, a trend that has left numerous AI company executives genuinely puzzled. Surveys...
May 18, 2026 - 02:07
Benchmark’s Bullish View Supports Spotify Technology S.A. (SPOT) as a Steve Cohen Large-Cap PickSpotify Technology S.A. (NYSE:SPOT) has landed on billionaire investor Steve Cohen`s radar as one of his top large-cap stock picks with significant upside potential. The streaming giant continues...